why choose us

Clinical Trials Search

Showing 8,120 of 132,085 result(s)
Virtual Sedation During Elective Procedures in the Cathlab

Status: Completed

Condition: Anxiety

Interventions: Distraction therapy using a virtual reality headset.
Participants will access a digitally created environment such as a forest or sub sea explora

Date: 2023-09-08

Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children

Status: Completed

Condition: Fever After Vaccination

Interventions: ACIP Recommended Vaccine

Date: 2023-09-08

A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2

Status: ACTIVE_NOT_RECRUITING

Condition: COVID-19

Interventions: Participants will be dosed on Day 1 followed by redosing at Month 3 (approximately 90 days) with VYD222.

Date: 2023-09-08

Vision Loss Impact on Navigation in Virtual Reality

Status: Completed

Condition: Stroke, Ischemic

Interventions: Participants will steer a virtual car with the goal of staying in the center of a single-lane roadway while traveling at a constant speed of 26.6 m&#x

Date: 2023-09-08

Glioblastoma Psychosocial Support Program

Status: Completed

Condition: Glioblastoma

Interventions: Participants will receive six weekly 60-minute sessions conducted by videoconference.

Date: 2023-09-08

VIDAS® NEPHROCLEAR Reference Interval Study

Status: ACTIVE_NOT_RECRUITING

Condition: Healthy

Interventions: Previously collected urine samples will be tested using the VIDAS® NEPHROCLEAR™ CCL14 Test

Date: 2023-09-07

The Effect of N115 on Coughing in IPF Patients

Status: Completed

Condition: Idiopathic Pulmonary Fibrosis

Interventions: The product is a 20 mM (0.2%, 2.2 mg;mL) sodium pyruvate nasal spray in 0.9% sodium chloride with 0.02% benzalkonium chloride preservative, pH 7.

Date: 2023-09-07

Study of ALE.C04 in Patients With Head and Neck Cancer

Status: Completed

Condition: Head and Neck Cancer

Interventions: Q3W

Date: 2023-09-07

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

Status: Completed

Condition: Chronic Inducible Urticaria

Interventions: Once daily

Date: 2023-09-07

VIDAS® NEPHROCLEAR Diagnostic Accuracy Study

Status: ACTIVE_NOT_RECRUITING

Condition: Acute Kidney Injury

Interventions: Urine samples previously collected from persons with stage 2;stage 3 AKI will be tested using the VIDAS® NEPHROCLEAR™ CCL14 Test

Date: 2023-09-07